Search

  1. ProQR Announces First Quarter 2020 Operating and Financial Results

    Press release

    … ProQR Announces First Quarter 2020 Operating and Financial … & CAMBRIDGE, Mass., May 07, 2020 (GLOBE NEWSWIRE) --  ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … for the same period last year. Research and development (R&D) costs were €12.8 million for the quarter ended March 31, …

  4. ProQR to Participate in the Kempen Life Sciences Conference

    Press release

    … ProQR to Participate in the Kempen Life Sciences Conference … & CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … Kempen Life Sciences Conference on April 20, 2022. About ProQR ProQR Therapeutics is dedicated to changing lives …

  5. ProQR to Present at the Evercore ISI HealthConX Conference

    Press release

    … ProQR to Present at the Evercore ISI HealthConX Conference … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …

  7. ProQR to Present at Two Investor Conferences in October

    Press release

    … ProQR to Present at Two Investor Conferences in October … Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … will be held from October 2-4, 2019 in New York, NY. ProQR will present on Wednesday, October 2, 2019 at 3:35 pm …

  9. ProQR to Present at Three Scientific Conferences in April

    Press release

    … ProQR to Present at Three Scientific Conferences in April … and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … K. Koenekoop, MD, PhD, principle investigator of the ProQR Phase 1/2 STELLAR clinical trial of QR-421a and …